Press Releases :: XORTX Therapeutics Inc. (XRTX)

Nov 16, 2022 7:00am EST

XORTX Therapeutics Appoints Stacy Evans, M.D., MBA as Chief Business Officer

Nov 03, 2022 5:00pm EDT

XORTX Presents New Proof of Concept Data at American Society of Nephrology

Nov 03, 2022 10:15am EDT

XORTX Announces Participation at Upcoming Investor Conferences

Oct 26, 2022 7:00am EDT

XORTX Receives Further No Objection Letter from Health Canada

Oct 25, 2022 7:00am EDT

XORTX Sponsored American Society of Nephrology Study Abstract Available Online

Oct 07, 2022 6:02pm EDT

XORTX Announces Closing of US$5 Million Public Offering

Oct 04, 2022 8:30am EDT

XORTX Announces US$5 Million Public Offering

Sep 19, 2022 7:00am EDT

XORTX Completes Positive Pre-Phase 3 Meeting with the US Food and Drug Administration

Sep 01, 2022 7:00am EDT

XORTX Sponsored Study Selected for Presentation at the American Society of Nephrology – Kidney Week 2022

Aug 22, 2022 7:00am EDT

XORTX Announces Positive Topline Results from Part 2 Pharmacokinetics Bridging Study

rss_feed News RSS